loading
Terns Pharmaceuticals Inc stock is traded at $6.93, with a volume of 1.30M. It is up +2.51% in the last 24 hours and up +15.50% over the past month. Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
See More
Previous Close:
$6.76
Open:
$6.77
24h Volume:
1.30M
Relative Volume:
1.39
Market Cap:
$606.45M
Revenue:
-
Net Income/Loss:
$-95.90M
P/E Ratio:
-5.25
EPS:
-1.32
Net Cash Flow:
$-79.09M
1W Performance:
-1.70%
1M Performance:
+15.50%
6M Performance:
+73.03%
1Y Performance:
-11.94%
1-Day Range:
Value
$6.59
$7.07
1-Week Range:
Value
$6.2324
$7.16
52-Week Range:
Value
$1.865
$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name
Name
Terns Pharmaceuticals Inc
Name
Phone
650-525-5535 EXT.101
Name
Address
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Name
Employee
59
Name
Twitter
Name
Next Earnings Date
2024-11-12
Name
Latest SEC Filings
Name
TERN's Discussions on Twitter

Compare TERN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TERN
Terns Pharmaceuticals Inc
6.93 591.57M 0 -95.90M -79.09M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-28-25 Initiated William Blair Mkt Perform
Oct-31-24 Initiated Oppenheimer Outperform
Jun-22-23 Initiated Mizuho Buy
Jun-07-23 Initiated Jefferies Buy
May-31-23 Initiated ROTH MKM Buy
May-08-23 Initiated BMO Capital Markets Outperform
Feb-14-23 Initiated JMP Securities Mkt Outperform
Feb-07-23 Initiated UBS Buy
Sep-12-22 Initiated H.C. Wainwright Neutral
Sep-14-21 Resumed Goldman Buy
Mar-02-21 Initiated Cowen Outperform
Mar-02-21 Initiated Goldman Buy
Mar-02-21 Initiated JP Morgan Overweight
View All

Terns Pharmaceuticals Inc Stock (TERN) Latest News

pulisher
Aug 20, 2025

RSI Suggests Rebound May Be Near in Terns Pharmaceuticals Inc.CEO Change & Safe Entry Trade Reports - newsyoung.net

Aug 20, 2025
pulisher
Aug 20, 2025

Terns Pharmaceuticals Inc. Nearing Breakout Level After BounceJuly 2025 Closing Moves & AI Driven Price Forecasts - thegnnews.com

Aug 20, 2025
pulisher
Aug 20, 2025

Institutional Tools Highlight Unusual Flow in Terns Pharmaceuticals Inc.July 2025 Momentum & Real-Time Volume Triggers - beatles.ru

Aug 20, 2025
pulisher
Aug 19, 2025

Terns Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Breakouts & Weekly High Return Opportunities - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Key metrics from Terns Pharmaceuticals Inc.’s quarterly dataJuly 2025 Opening Moves & Technical Buy Zone Confirmations - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Terns Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Setups & AI Enhanced Trading Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Can trapped investors hope for a rebound in Terns Pharmaceuticals Inc.July 2025 Sector Moves & Stepwise Trade Execution Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Applying chart zones and confluence areas to Terns Pharmaceuticals Inc.July 2025 Price Swings & Consistent Growth Equity Picks - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Sentiment analysis tools applied to Terns Pharmaceuticals Inc.2025 Risk Factors & Growth-Oriented Investment Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Best data tools to analyze Terns Pharmaceuticals Inc. stockMarket Sentiment Review & Growth Focused Investment Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using AI based signals to follow Terns Pharmaceuticals Inc.July 2025 Setups & Weekly Watchlist for Hot Stocks - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Multi asset correlation models including Terns Pharmaceuticals Inc.Weekly Market Outlook & Verified Swing Trading Watchlists - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Terns Pharmaceuticals Inc. stock bottoming outJuly 2025 Spike Watch & High Yield Stock Recommendations - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Is Terns Pharmaceuticals Inc. a play on infrastructure spendingWeekly Profit Report & Free Safe Capital Growth Stock Tips - thegnnews.com

Aug 16, 2025
pulisher
Aug 16, 2025

Will earnings trigger a reversal in Terns Pharmaceuticals Inc.Weekly Investment Summary & Free Long-Term Investment Growth Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Terns Pharmaceuticals Inc. At Critical Juncture — Bounce or BreakdownPortfolio Profit Report & Technical Pattern Recognition Alerts - metal.it

Aug 16, 2025
pulisher
Aug 15, 2025

Terns Pharmaceuticals Inc (TERN) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

Aug 15, 2025
pulisher
Aug 15, 2025

What institutional flow reveals about Terns Pharmaceuticals Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

What makes Terns Pharmaceuticals Inc. stock price move sharplyMarket Activity Summary & Fast Gain Swing Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Is It Too Late to Sell Terns Pharmaceuticals Inc.2025 Market Sentiment & Real-Time Market Sentiment Reports - classian.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data - Investing.com Nigeria

Aug 14, 2025
pulisher
Aug 14, 2025

Terns Pharmaceuticals’ SWOT analysis: obesity drug stock poised for pivotal data By Investing.com - Investing.com South Africa

Aug 14, 2025
pulisher
Aug 14, 2025

Analyzing Sangamo Therapeutics (NASDAQ:SGMO) & Terns Pharmaceuticals (NASDAQ:TERN) - Defense World

Aug 14, 2025
pulisher
Aug 13, 2025

Analyzing drawdowns of Terns Pharmaceuticals Inc. with statistical toolsJuly 2025 Trade Ideas & Fast Moving Stock Trade Plans - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Heatmap analysis for Terns Pharmaceuticals Inc. and competitorsLong Term Stock Planner with Safety Checks - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Does Terns Pharmaceuticals Inc. show high probability of reboundFree Breakout Confirmation With Entry Tracker - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Terns Pharmaceuticals Reports Q2 2025 Financial Results - TipRanks

Aug 10, 2025
pulisher
Aug 10, 2025

Custom strategy builders for tracking Terns Pharmaceuticals Inc.Downside Control Plan With Support Analysis - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

William Blair Has Positive Outlook of TERN FY2025 Earnings - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

How Terns Pharmaceuticals Inc. stock performs during market volatilityFree Portfolio Diversification Stock Ideas - Newser

Aug 08, 2025

Terns Pharmaceuticals Inc Stock (TERN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Terns Pharmaceuticals Inc Stock (TERN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Gengos Andrew
Chief Financial Officer
Jun 27 '25
Buy
3.93
10,000
39,283
25,000
Burroughs Amy L.
Chief Executive Officer
Jun 25 '25
Buy
3.87
23,314
90,230
47,083
Gengos Andrew
Chief Financial Officer
Jun 13 '25
Buy
3.73
10,000
37,350
10,000
Gengos Andrew
Chief Financial Officer
Jun 16 '25
Buy
3.95
5,000
19,732
15,000
Kuriakose Emil
Chief Medical Officer
Apr 01 '25
Sale
2.49
952
2,366
53,317
Jung Melita Sun
Chief Business Officer
Nov 30 '24
Buy
5.11
2,250
11,498
2,250
Burroughs Amy L.
Chief Executive Officer
Nov 30 '24
Buy
5.11
510
2,606
19,609
Kuriakose Emil
Chief Medical Officer
Jan 02 '25
Sale
5.71
4,481
25,607
54,269
Vignola Mark J.
Chief Financial Officer
Jan 06 '25
Sale
5.80
9,059
52,500
74,752
Vignola Mark J.
Chief Financial Officer
Jan 02 '25
Sale
5.72
8,129
46,524
83,811
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):